{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-24-001316","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.599426+00:00","generated_at":"2026-06-05T04:42:54.302039+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Zeo ScientifiX (f/k/a Organicell) changes name and ticker to ZEOX effective March 5, 2024","bullets":["FINRA approved corporate name change from Organicell Regenerative Medicine to Zeo ScientifiX and symbol from OCEL to ZEOX, effective at market open March 5, 2024.","CUSIP number for common stock remains unchanged.","CEO Harry Leider highlighted Phase 1 completion, Phase 2 plans, and recent additions to the executive team."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-24-001316","json":"https://secwatch.observer/filing/0001829126-24-001316.json","markdown":"https://secwatch.observer/filing/0001829126-24-001316.md","text":"https://secwatch.observer/filing/0001829126-24-001316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624001316/0001829126-24-001316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912624001316/zeoscientifixinc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:42:54.302039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}